A new study reveals that the amino acid arginine can significantly reduce toxic amyloid protein buildup and inflammation in animal models of Alzheimer's disease.
Researchers discovered that boosting a protein called Sox9 helps the brain's astrocytes clear Alzheimer's plaques and preserve cognitive function in mice.
Researchers have studied SuperAgers, individuals over 80 with memory like 50-year-olds, finding unique brain structures and social traits that resist or adapt to Alzheimer's-related changes.
A routine blood test marker, the neutrophil to lymphocyte ratio, may predict a person's risk of developing Alzheimer's disease years before symptoms appear, suggesting immune cells could play a role in the disease's progression.